摘要
目的:建立CRISPR/Cas9系统用于敲除人源雌激素受体α(ERα)基因(ESR1),并利用此细胞模型初步检测ESR1基因对乳腺癌细胞侵袭能力的影响。方法:设计一个靶向人源ESR1基因第2外显子的单向导RNA(sg RNA),分别克隆表达载体后,通过慢病毒转入人乳腺癌细胞株MCF-7,Western印迹检测MCF-7中ESR1基因的敲除效果,通过Transwell、反向侵袭试验观察ESR1基因敲除后对细胞侵袭能力的影响。结果:测序结果显示靶向ESR1基因CRISPR/Cas9重组质粒构建成功;Western印迹显示Cas9-ERα组的MCF-7细胞内ERα表达水平较对照组显著降低;Tanswell、反向侵袭试验证实ESR1基因敲除能够促进乳腺癌细胞的侵袭能力。结论:通过CRISPR/Cas9系统获得了靶向ESR1基因的重组质粒,构建的重组质粒能有效敲除ESR1基因;ERα能够抑制乳腺癌细胞的侵袭能力。
Objective:To knock out human estrogen receptorα1(ERα)gene(ESR1)by CRISPR/Cas9system.Methods:A sgRNA targeting the exon2of human ESR1gene was designed and cloned into vector,then it was transfected into human MCF-7cells by lentivirus.The effect of recombination plasmid on the expression of ESR1gene was identified by Western blot assays.The invasive ability of cells was examined by the transwell assay.Results:Western blotting showed that ERαsignificantly decreased in Cas9-ERαgroup.Inverse invasion assay and transwell assay showed that ESR1gene knock out promoted the invasion of breast cancer cells.Conclusion:The CRISPR/Cas9palsmid targeting human ESR1gene was successfully constructed and could knock out the expression of ESR1gene effectively.ERαcan inhibit the invasion of breast cancer cells.
作者
孙嘉慧
栗梓仓
李志科
韩丹丹
鲍树森
曾诚
张存
SUN Jia-Hui;LI Zi-Cang;LI Zhi-Ke;HAN Dan-Dan;BAO Shu-Sen;ZENG Cheng;ZHANG Cun(Department of Biopharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China)
出处
《生物技术通讯》
CAS
2017年第6期785-788,共4页
Letters in Biotechnology
基金
国家自然科学基金(81472484)